GPCR — Structure Therapeutics Balance Sheet
0.000.00%
- $1.83bn
- $1.39bn
- 30
- 26
- 35
- 20
Annual balance sheet for Structure Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 37.4 | 107 | 90.8 | 467 |
Prepaid Expenses | ||||
Total Current Assets | 38.4 | 109 | 93.1 | 474 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.277 | 1.79 | 1.29 | 8.36 |
Other Long Term Assets | ||||
Total Assets | 38.7 | 111 | 97.8 | 482 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 3.04 | 8.66 | 13 | 24.7 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 3.17 | 8.93 | 13 | 29.1 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 35.5 | 102 | 84.8 | 453 |
Total Liabilities & Shareholders' Equity | 38.7 | 111 | 97.8 | 482 |
Total Common Shares Outstanding | ||||
Total Preferred Shares Outstanding |